Related Experiment Video
Updated: Jun 10, 2026
17:28
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Validation of alternative toxicity tests: Principles, practices and cases.
1Department of Human Morphology, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, UK; FRAME (Fund for the Replacement of Animals in Medical Experiments), 34 Stoney Street, Nottingham NG1 1NB, UK.
Summary
Properly validated in vitro toxicity tests are crucial for regulatory acceptance. This study analyzes cell growth inhibition tests and their correlation with animal LD50 values, offering insights for future validation schemes.
Area of Science:
- Toxicology
- In vitro testing
- Regulatory science
Background:
- In vitro toxicity tests require rigorous scientific validation for regulatory and legal acceptance.
- The FRAME Alternative Test Validation Scheme provides a framework for evaluating these tests.
- Assessing the reliability and relevance of alternative methods is critical in toxicology.
Purpose of the Study:
- To report lessons learned from administering the FRAME Alternative Test Validation Scheme.
- To analyze correlations between in vitro cell growth inhibition tests and in vivo LD50 values.
- To provide recommendations for designing future test validation schemes.
Main Methods:
- Correlational analysis of results from multiple cell growth inhibition tests.
- Comparison of in vitro test results with rat oral and mouse intraperitoneal LD50 values.
- Evaluation of data generated within the FRAME Alternative Test Validation Scheme.
Main Results:
- Identified correlations between different in vitro cell growth inhibition assays.
- Observed varying degrees of correlation between in vitro tests and in vivo LD50 values.
- Highlighted the importance of careful test selection and validation in the scheme.
Conclusions:
- Scientific validation of in vitro toxicity tests is paramount before regulatory consideration.
- Lessons from the FRAME scheme inform the design of more effective validation processes.
- Further refinement of validation strategies is needed to ensure the reliability of alternative toxicity testing methods.
Related Concept Videos
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:26Toxic Reactions: Overview
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
01:21Toxicokinetics: Overview
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:36Types of Toxins
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...